nystatin orifarm 100 000 ie/ml oral suspension
orifarm generics a/s - nystatin - oral suspension - 100 000 ie/ml - metylparahydroxibensoat hjälpämne; xylitol hjälpämne; nystatin 100000 ie aktiv substans
trelema 10 mg/ml sirap
g.l. pharma gmbh - lakosamid - sirap - 10 mg/ml - sorbitol hjälpämne; glycerol 85% hjälpämne; lakosamid 10 mg aktiv substans; metylparahydroxibensoat hjälpämne
karbamid evolan 50 mg/g kräm
evolan pharma ab - urea - kräm - 50 mg/g - propylenglykol hjälpämne; etylparahydroxibensoat hjälpämne; cetostearylalkohol hjälpämne; metylparahydroxibensoat hjälpämne; urea 50 mg aktiv substans
senstend
plethora pharma solutions limited - lidokain, prilocaine - för tidig utlösning - bedövningsmedel - senstend är indicerat för behandling av primär tidig utlösning hos män.
lacosamide medical valley 10 mg/ml sirap
medical valley invest ab - lakosamid - sirap - 10 mg/ml - metylparahydroxibensoat hjälpämne; glycerol 85% hjälpämne; sorbitol hjälpämne; lakosamid 10 mg aktiv substans
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiska medel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
vipdomet
takeda pharma a/s - alogliptin benzoate, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. trippel kombinationsterapi) som ett komplement till diet och motion för att förbättra glykemisk kontroll hos patienter när insulin på en stabil dos och enbart metformin inte ger tillräcklig glykemisk kontroll.
cleonita 0,02 mg/3 mg filmdragerad tablett
ebb medical ab - drospirenon; etinylestradiol - filmdragerad tablett - 0,02 mg/3 mg - laktos (vattenfri) hjälpämne; drospirenon 3 mg aktiv substans; laktosmonohydrat hjälpämne; etinylestradiol 0,02 mg aktiv substans - drospirenon och etinylestradiol
letrozol orion 2,5 mg filmdragerad tablett
orion corporation - letrozol - filmdragerad tablett - 2,5 mg - laktosmonohydrat hjälpämne; tartrazin aluminiumlack hjälpämne; letrozol 2,5 mg aktiv substans